OTC · Drug Manufacturers - Specialty & Generic

Alterola Biotech, Inc. (ABTI) Stock

$0.00 OTC: ABTI Healthcare

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules.

Valuation

MetricValue
Price$0.00
Market Cap$291900
P/E Ratio-0.11
P/B Ratio0.03
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.20
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.00%
ROA-16.67%
ROCE-18.51%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.10
Current Ratio0.11

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$0$0$0$-6.0M$-2.0M
Net Profit$0$0$0$-6.0M$-2.0M
EPS$0.00$0.00$0.00$-0.01$0.00
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$0$0$0$12.0M$12.0M
Total Liabilities$0$0$0$1.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$1.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$0$0$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$1.0M
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.00
FCF Yield-404.11%
Quick Ratio0.11
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-97.94%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Alterola Biotech, Inc.

Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.

Alterola Biotech, Inc. (ABTI) stock trades at $0.00 with a market capitalization of $291900. The stock is valued at a price-to-earnings (P/E) ratio of -0.11, price-to-book of 0.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.20, and currently trades 100.0% below its 52-week high.

On profitability, Alterola Biotech, Inc. generates a return on equity (ROE) of -20.00%, return on capital employed of -18.51%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: alterola-abti.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides